Nathalie C.
- Country
- Belgium
- Department
- Oncology
Research Overview
- A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11/GOG-3047)
- A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
- Evaluation of Durvalumab as Adjuvant Therapy in Mismatch Repair-Deficient High-Risk Endometrial Cancer Post-Surgery: A Phase III Clinical Trial
Data & Insights
Has run more than one trial at 34 of 129 partner sites.
Specializations
Ovarian Cancer Research
Specializes in treating advanced high-grade ovarian cancer, with particular focus on patients with HRD-positive tumors. The investigator's work encompasses fallopian tube cancer and primary peritoneal cancer management, including clear cell carcinoma variants.
- Post-surgical tumor management
- Chemotherapy optimization
- Maintenance therapy approaches
Explores innovative treatment strategies for patients following primary tumor debulking procedures.
Cervical Cancer Focus
Dedicated to advancing treatment protocols for locally advanced cervical cancer, investigating the integration of immunotherapy with traditional treatment approaches. Specializes in combining chemoradiotherapy with novel therapeutic agents.
- Concurrent therapy strategies
- Disease progression assessment
- Survival outcome evaluation
Focuses on developing comprehensive treatment approaches for high-risk cervical cancer patients.
Endometrial Cancer Expertise
Conducts research in high-risk endometrial cancer treatment, with specific attention to mismatch-repair deficient (MMRd) variants. Investigates post-surgical therapeutic strategies including adjuvant chemotherapy and radiotherapy combinations.
- Molecular-based treatment refinement
- Post-surgical therapy optimization
- Recurrence prevention strategies
Specializes in curative approaches for various stages of endometrial cancer, from early to advanced disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.